Nvidia Corp. will invest $1 billion over five years to establish a new artificial intelligence laboratory in collaboration with Eli Lilly & Co. The facility, located in Silicon Valley, aims to accelerate the application of AI in the pharmaceutical industry by leveraging Lilly's lab expertise.

• Nvidia will invest $1 billion over five years to build an AI drug discovery lab with Eli Lilly, located in Silicon Valley
• The lab will use Lilly's lab expertise combined with Nvidia's computational tools to predict how compounds interact with biological systems
• The goal is to speed up and cut costs in drug discovery while improving precision in targeting specific diseases
• The deal signals Nvidia's strategic push into healthcare as a growth area beyond its core computing and gaming business

As the new year begins, the author reflects on a more active approach to cryptocurrency trading while maintaining a lean portfolio. Highlighting the AI Agent sector and upcoming protocols like x402 and ERC-8004, they present four low-cap tokens worth researching, emphasizing the potential for gains despite the overall market's risks.

• Author is shifting to more active trading in 2026 while still keeping the overall portfolio lean/concentrated
• AI Agent sector flagged as a key theme to watch, tied to emerging protocols x402 and ERC-8004
• Four specific low-cap tokens are named as worth researching for potential upside
• Acknowledges elevated risk in the broader market despite highlighting these opportunities

Bridgewater founder Ray Dalio cautioned that the current AI boom is in the early stages of a bubble, following significant gains in Wall Street's technology stocks. He noted that while the Federal Reserve may lower interest rates, investors are beginning to seek opportunities beyond highly valued tech stocks due to concerns over potential overvaluation.

• Ray Dalio says the AI boom is in the early stages of a bubble, following steep gains in tech stocks
• Investors are starting to look for opportunities beyond highly valued tech stocks over overvaluation concerns
• The Federal Reserve may cut interest rates